KAYLA GARDIENT: Open Payments
NPI 1881702959 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 10 payments from 7 companies in 2025. Trend: 2023 $378 · 2024 $259 · 2025 $182
Food & beverage: $182
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
| Abbott Laboratories | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: WAINUA, FARXIGA, NEXLETOL, VYNDAQEL, CAMZYOS, Rybelsus, CARDIOMEMS, SHINGRIX.
Industry payments across NE — which companies pay providers there.
